Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage.
Colao A, Di Sarno A, Landi ML, Cirillo S, Sarnacchiaro F, Facciolli G, Pivonello R, Cataldi M, Merola B, Annunziato L, Lombardi G.
Colao A, et al.
J Clin Endocrinol Metab. 1997 Nov;82(11):3574-9. doi: 10.1210/jcem.82.11.4368.
J Clin Endocrinol Metab. 1997.
PMID: 9360509
Clinical Trial.